Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1981 Apr;67(4):1083–1093. doi: 10.1172/JCI110121

Increased Thirst and Plasma Arginine Vasopressin Levels during 2-Deoxy-d-glucose-induced Glucoprivation in Humans

D A Thompson 1,2,3,4, R G Campbell 1,2,3,4, U Lilavivat 1,2,3,4, S L Welle 1,2,3,4, G L Robertson 1,2,3,4
PMCID: PMC370668  PMID: 7204569

Abstract

Insulin-induced hypoglycemia by unknown mechanism(s) increases plasma arginine vasopressin (AVP) levels in humans. Mechanisms for increased AVP levels during central nervous system glucoprivation were investigated by administering 20-min i.v. infusions of 2-deoxy-d-glucose (50 mg/kg), a competitive inhibitor of glucose utilization, or normal saline (sham), to 24 normal volunteers. Some of the infusions were administered in combination with neuropharmacological blocking agents (placebo). The behavioral, physiological, metabolic, and hormonal correlates of 2-deoxy-d-glucose (2DG)-induced gluco-privation and AVP secretion were studied in a group (n = 5) pretreated for 1 wk with either mazindol (1 mg per os three times per day), a potent norepinephrine and dopamine-reuptake blocker, or placebo. A second group (n = 5) received either propranolol (3 mg/3 min followed by 80 μg/min) or normal saline infusion before and during 2DG administration. With 2DG alone, plasma AVP levels increased from 1.3±0.3 pg/ml at base line to a peak of 4.5±1.4 pg/ml at 60 min and remained elevated for 150 min. From 30 to 180 min after 2DG administration, the 2DG-infused volunteers increased their water intake in comparison with sham-infused volunteers. Marked increases in epinephrine and slight increases in norepinephrine were associated with increases in plasma glucose and renin activity and decreases in plasma potassium. Plasma sodium and osmolality increased transiently and mean arterial pressure (MAP) fell. These changes, however, were small and inconstant and could not account for the observed increases in thirst and AVP levels. Pretreatment with mazindol prevented the decrease in MAP and the increase in plasma renin activity (PRA) following 2DG infusions without modifying increased thirst, water intake, or AVP responses to glucoprivation. Pretreatment with propranolol effectively blocked β-adrenoreceptors as evidenced by increased MAP and plasma epinephrine, and abolition of the RPA increases during 2DG-induced glycoprivation, but did not suppress AVP and thirst responses. A cervical cord-sectioned patient lacking descending sympathetic out-flow had a potentiated thirst response to 2DG-induced glucoprivation in the absence of increases in sodium, catecholamines, and PRA. Thus 2DG administration activates mechanisms for increased thirst and AVP which are unrelated to changes in peripheral catecholamines, MAP, PRA, and osmolality.

Full text

PDF
1083

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDRES R., BALTZAN M. A., CADER G., ZIERLER K. L. Effect of insulin on carbohydrate metabolism and on potassium in the forearm of man. J Clin Invest. 1962 Jan;41:108–115. doi: 10.1172/JCI104452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BORDLEY J., 3rd, CONNOR C. A. R., HAMILTON W. F., KERR W. J., WIGGERS C. J. Recommendations for human blood pressure determinations by sphygmomanometers. Circulation. 1951 Oct;4(4):503–509. doi: 10.1161/01.cir.4.4.503. [DOI] [PubMed] [Google Scholar]
  3. Baylis P. H., Heath D. A. Plasma-arginine-vasopressin response to insulin-induced hypoglycaemia. Lancet. 1977 Aug 27;2(8035):428–430. doi: 10.1016/s0140-6736(77)90610-9. [DOI] [PubMed] [Google Scholar]
  4. Berthoud H. R., Mogenson G. J. Ingestive behavior after intracerebral and intracerebroventricular infusions of glucose and 2-deoxy-D-glucose. Am J Physiol. 1977 Sep;233(3):R127–R133. doi: 10.1152/ajpregu.1977.233.3.R127. [DOI] [PubMed] [Google Scholar]
  5. Brodows R. G., Pi-Sunyer, Campbell R. G. Sympathetic control of hepatic glycogenolysis during glucopenia in man. Metabolism. 1975 May;24(5):617–624. doi: 10.1016/0026-0495(75)90141-9. [DOI] [PubMed] [Google Scholar]
  6. Brodows R. G., Pi-Sunyer F. X., Campbell R. G. Neural control of counter-regulatory events during glucopenia in man. J Clin Invest. 1973 Aug;52(8):1841–1844. doi: 10.1172/JCI107366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davies R., Forsling M. L., Slater J. D. The interrelationship between the release of renin and vasopressin as defined by orthostasis and propranolol. J Clin Invest. 1977 Dec;60(6):1438–1441. doi: 10.1172/JCI108905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Elghozi J. L., Fitzsimons J. T., Meyer P., Nicolaïdis S. Central angiotensin in the control of water intake and blood pressure. Prog Brain Res. 1977;47:137–149. doi: 10.1016/S0079-6123(08)62720-X. [DOI] [PubMed] [Google Scholar]
  9. Fitzsimons J. T. Thirst. Physiol Rev. 1972 Apr;52(2):468–561. doi: 10.1152/physrev.1972.52.2.468. [DOI] [PubMed] [Google Scholar]
  10. Freinkel N., Metzger B. E., Harris E., Robinson S., Mager M. The hypothermia of hypoglycemia. Studies with 2-deoxy-D-glucose in normal human subjects and mice. N Engl J Med. 1972 Oct 26;287(17):841–845. doi: 10.1056/NEJM197210262871702. [DOI] [PubMed] [Google Scholar]
  11. Genest J., Nowaczynski W., Kuchel O., Boucher R., Rojo-Ortega J. M. The role of the adrenal cortex in human essential hypertension: keynote address. Mayo Clin Proc. 1977 May;52(5):291–307. [PubMed] [Google Scholar]
  12. Hedeland H., Dymling J. F., Hökfelt B. The effect of insulin induced hypoglycaemia on plasma renin activity and urinary catecholamines before and following clonidine (Catapresan) in man. Acta Endocrinol (Copenh) 1972 Oct;71(2):321–330. doi: 10.1530/acta.0.0710321. [DOI] [PubMed] [Google Scholar]
  13. Himathongkam T., Dluhy R. G., Williams G. H. Potassim-aldosterone-renin interrelationships. J Clin Endocrinol Metab. 1975 Jul;41(1):153–159. doi: 10.1210/jcem-41-1-153. [DOI] [PubMed] [Google Scholar]
  14. Kimura T., Minai K., Matsui K., Mouri T., Sato T. Effect of various states of hydration on plasma ADH and renin in man. J Clin Endocrinol Metab. 1976 Jan;42(1):79–87. doi: 10.1210/jcem-42-1-79. [DOI] [PubMed] [Google Scholar]
  15. Lilavivathana U., Brodows R. G., Woolf P. D., Campbell R. G. Counterregulatory hormonal responses to rapid glucose lowering in diabetic man. Diabetes. 1979 Oct;28(10):873–877. doi: 10.2337/diab.28.10.873. [DOI] [PubMed] [Google Scholar]
  16. McDonald K. M., Miller P. D., Anderson R. J., Berl T., Schrier R. W. Hormonal control of renal water excretion. Kidney Int. 1976 Jul;10(1):38–45. doi: 10.1038/ki.1976.77. [DOI] [PubMed] [Google Scholar]
  17. Nilsson O. R., Karlberg B. E., Söderberg A. Plasma catecholamines and cardiovascular responses to hypoglycemia in hyperthyroidism before and during treatment with metoprolol or propranolol. J Clin Endocrinol Metab. 1980 May;50(5):906–911. doi: 10.1210/jcem-50-5-906. [DOI] [PubMed] [Google Scholar]
  18. Passon P. G., Peuler J. D. A simplified radiometric assay for plasma norepinephrine and epinephrine. Anal Biochem. 1973 Feb;51(2):618–631. doi: 10.1016/0003-2697(73)90517-4. [DOI] [PubMed] [Google Scholar]
  19. Peytremann A., Favre L., Vallotton M. B. Effect of cold pressure test and 2-deoxy-D-glucose infusion on plasma renin activity in man. Eur J Clin Invest. 1972 Nov;2(6):432–438. doi: 10.1111/j.1365-2362.1972.tb00674.x. [DOI] [PubMed] [Google Scholar]
  20. Porte D., Jr, Graber A. L., Kuzuya T., Williams R. H. The effect of epinephrine on immunoreactive insulin levels in man. J Clin Invest. 1966 Feb;45(2):228–236. doi: 10.1172/JCI105335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Porte D., Jr Sympathetic regulation of insulin secretion. Its relation to diabetes mellitus. Arch Intern Med. 1969 Mar;123(3):252–260. [PubMed] [Google Scholar]
  22. ROBERTS L. N., SMILEY J. R., MANNING G. W. A comparison of direct and indirect blood-pressure determinations. Circulation. 1953 Aug;8(2):232–242. doi: 10.1161/01.cir.8.2.232. [DOI] [PubMed] [Google Scholar]
  23. Robertson G. L., Mahr E. A., Athar S., Sinha T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest. 1973 Sep;52(9):2340–2352. doi: 10.1172/JCI107423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Robertson G. L. The regulation of vasopressin function in health and disease. Recent Prog Horm Res. 1976;33:333–385. doi: 10.1016/b978-0-12-571133-3.50015-5. [DOI] [PubMed] [Google Scholar]
  25. Rosa R. M., Silva P., Young J. B., Landsberg L., Brown R. S., Rowe J. W., Epstein F. H. Adrenergic modulation of extrarenal potassium disposal. N Engl J Med. 1980 Feb 21;302(8):431–434. doi: 10.1056/NEJM198002213020803. [DOI] [PubMed] [Google Scholar]
  26. Rowe J. W., Shelton R. L., Helderman J. H., Vestal R. E., Robertson G. L. Influence of the emetic reflex on vasopressin release in man. Kidney Int. 1979 Dec;16(6):729–735. doi: 10.1038/ki.1979.189. [DOI] [PubMed] [Google Scholar]
  27. Sugrue M. F., Shaw G., Charlton K. G. Some effects of mazindol, an anorectic drug, on rat brain monoaminergic systems. Eur J Pharmacol. 1977 Apr 21;42(4):379–385. doi: 10.1016/0014-2999(77)90172-8. [DOI] [PubMed] [Google Scholar]
  28. Thompson D. A., Campbell R. G. Hunger in humans induced by 2-deoxy-D-glucose: glucoprivic control of taste preference and food intake. Science. 1977 Dec 9;198(4321):1065–1068. doi: 10.1126/science.929188. [DOI] [PubMed] [Google Scholar]
  29. Uhlich E., Weber P., Eigler J., Gröschel-Stewart U. Angiotensin stimulated AVP-release in humans. Klin Wochenschr. 1975 Feb 15;53(4):177–180. doi: 10.1007/BF01466762. [DOI] [PubMed] [Google Scholar]
  30. WICK A. N., DRURY D. R., NAKADA H. I., WOLFE J. B. Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem. 1957 Feb;224(2):963–969. [PubMed] [Google Scholar]
  31. WOODWARD G. E., HUDSON M. T. The effect of 2-desoxy-D-glucose on glycolysis and respiration of tumor and normal tissues. Cancer Res. 1954 Sep;14(8):599–605. [PubMed] [Google Scholar]
  32. Weitzman R. E., Fisher D. A., DiStefano J. J., 3rd, Bennett C. M. Episodic secretion of arginine vasopressin. Am J Physiol. 1977 Jul;233(1):E32–E36. doi: 10.1152/ajpendo.1977.233.1.E32. [DOI] [PubMed] [Google Scholar]
  33. Welle S. L., Thompson D. A., Campbell R. G., Lilavivathana U. Increased hunger and thirst during glucoprivation in humans. Physiol Behav. 1980 Sep;25(3):397–403. doi: 10.1016/0031-9384(80)90279-6. [DOI] [PubMed] [Google Scholar]
  34. Woolf P. D., Lee L. A., Leebaw W., Thompson D., Lilavivathana U., Brodows R., Campbell R. Intracellular glucopenia causes prolactin release in man. J Clin Endocrinol Metab. 1977 Sep;45(3):377–383. doi: 10.1210/jcem-45-3-377. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES